Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Director, HRBP
Brisbane, California · Posted on May 7, 2025
Automation Service Engineer III
Brisbane, California · Posted on May 6, 2025
Manager, Accounting
Brisbane, California · Posted on May 6, 2025
Manager, Automation Engineering
Brisbane, California · Posted on May 6, 2025
Vice President, Field Medical & Advocacy
Brisbane, California · Posted on May 6, 2025
Associate Director, Product Management
Brisbane, California · Posted on May 5, 2025
Automation Engineer III
Brisbane, California · Posted on May 5, 2025
Director, Sales Operations & Analytics
Brisbane, California · Posted on May 5, 2025
Future Consideration
Brisbane, California · Posted on May 5, 2025
Manager, Commercial Program Management
Remote · Posted on May 5, 2025
Manager, Cost Accounting
Brisbane, California · Posted on May 5, 2025
Senior Application Integration Engineer I
Remote · Posted on May 5, 2025
Explore similar companies to Freenome
Collate
Automating paperwork for biotech.
Plenful
AI workflow platform for healthcare.
Eternal
Longevity care for athletes.
Thatch
Modern health benefits platform.
ClarityCare AI
Streamlining health insurance prior authorization.
Silna
Make care your primary focus.
Junction
Modernizing healthcare infrastructure.
RadiantGraph
Intelligent personalization for healthcare.
New Lantern
Automation radiolog-related tasks with AI.